honokiol has been researched along with Acute Confusional Senile Dementia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Huang, YF; Ip, SP; Li, QP; Lin, ZX; Qu, C; Su, ZR; Xian, YF; Xie, YL; Xu, QQ; Yang, W; Yuan, QJ | 1 |
Singh, L; Singh, S | 1 |
Buabeid, M; Dhanasekaran, M; Dwyer, D; Fabbrini, M; Fujihashi, A; Govindarajulu, M; Lynd, T; Mohanakumar, KP; Moore, T; Neel, L; Ramesh, S; Shah, K; Smith, F | 1 |
Jia, J; Jia, L; Jiao, H; Kong, C; Li, B; Li, W; Li, Y; Pang, Y; Qin, W; Wang, S; Wang, Y; Xu, L; Zhang, H | 1 |
Li, Y; Ni, C; Song, G; Wang, M | 1 |
Hou, T; Jia, J; Li, H; Tian, Y; Wang, W; Wang, X; Wei, Y; Wu, Q; Xu, L | 1 |
Akae, H; Akagi, M; Akagi, R; Fukuishi, N; Fukuyama, Y; Hirashima, N; Matsui, N | 1 |
Baum, L; Chow, AH; Ho, YP; Hoi, CP | 1 |
Anavi-Goffer, S; Gertsch, J | 1 |
2 review(s) available for honokiol and Acute Confusional Senile Dementia
Article | Year |
---|---|
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biphenyl Compounds; Dietary Supplements; Drug Delivery Systems; Enzyme Inhibitors; Glucosides; Humans; Hydrazines; Indazoles; Lignans; Neuroprotection; Phenols; Sirtuin 3 | 2021 |
Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Biphenyl Compounds; Cells, Cultured; Dietary Supplements; Hippocampus; Humans; Lignans; Magnolia; Mice; Molecular Weight; Nerve Growth Factors; Neurodegenerative Diseases; Neurogenesis; Phytotherapy; Polyphenols; Rats; Structure-Activity Relationship; Zingiberales | 2015 |
7 other study(ies) available for honokiol and Acute Confusional Senile Dementia
Article | Year |
---|---|
Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
Topics: Alzheimer Disease; Animals; Biphenyl Compounds; Cognition; Cognitive Dysfunction; Gastrointestinal Microbiome; Glycogen Synthase Kinase 3 beta; Lignans; Male; Mice; Neuroinflammatory Diseases | 2022 |
Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Maze Learning; Models, Theoretical; Neuroinflammatory Diseases; Neuroprotective Agents; Neurotransmitter Agents; NF-kappa B; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Streptozocin | 2023 |
Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Biphenyl Compounds; Cell Culture Techniques; Cell Survival; Humans; Lignans; Magnolia; Mice; Microglia; Phagocytosis; Reactive Oxygen Species | 2021 |
Honokiol Attenuates Oligomeric Amyloid β1-42-Induced Alzheimer's Disease in Mice Through Attenuating Mitochondrial Apoptosis and Inhibiting the Nuclear Factor Kappa-B Signaling Pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hippocampus; Lignans; Male; Maze Learning; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Neurons; NF-kappa B; Peptide Fragments; Reactive Oxygen Species; Signal Transduction | 2017 |
Honokiol Alleviates Cognitive Deficits of Alzheimer's Disease (PS1V97L) Transgenic Mice by Activating Mitochondrial SIRT3.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Biphenyl Compounds; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Female; Hippocampus; Lignans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Neurons; Oligoribonucleotides; Oxidative Stress; Presenilin-1; Rats; Rats, Sprague-Dawley; Sirtuin 3 | 2018 |
Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Biphenyl Compounds; Calcium; Caspase 3; Cell Survival; Drugs, Chinese Herbal; Lignans; Magnolia; Neuroprotective Agents; PC12 Cells; Rats; Reactive Oxygen Species | 2010 |
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
Topics: Alzheimer Disease; Animals; Biphenyl Compounds; Humans; Inflammation; Lignans; Plants, Medicinal; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2012 |